Global Arthrogryposis Management Market Overview and Strategic Insights
The global Arthrogryposis Management Market is poised for substantial growth, with market value expected to rise from USD 502.7 million in 2025 to USD 900.3 million by 2035 , registering a compound annual growth rate (CAGR) of 6.0% . The increasing prevalence of arthrogryposis multiplex congenita (AMC), rising awareness among healthcare providers, and adoption of multidisciplinary treatment approaches are driving this expansion. Arthrogryposis, a rare congenital disorder characterized by joint contractures, affects approximately 1 in every 3,000 live births and is equally prevalent among males and females. The disorder occurs across various populations, including Asian, African, and European descent, creating a global need for accessible and effective management solutions. Rising Demand for Multidisciplinary Arthrogryposis Care The growing recognition of AMC and its functional impact on patients’ daily lives is fueling demand for comprehensive treatment strategies . Multid...